Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease.

Kenton NT., Barr H., Cherepakha A., Coelmont L., Collard C., Cousins D., Davies GHM., Degtyarenko O., Dirksen A., Elbrecht D., Fearon D., Gayvert J., Griffen E., Jochmans D., Kaptein S., Kliatskiy P., Kochetkov A., Kordubailo M., Lahav N., London N., Maas E., Marples P., Nady N., Neyts J., Nguyen L., Ni X., Ogorodnik Y., Robinson MC., Simpson CT., Tarabara I., Tkachenko A., von Delft A., von Delft F., Yakymenko O., Lee AA.

DOI

10.1101/2025.06.19.660642

Type

Preprint

Publication Date

2025-06-20T00:00:00+00:00

Permalink More information Close